Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AHCY | P23526 | 8/20 | 0.60 |
| ▸ | TMEM97 | Q5BJF2 | 2/20 | 0.56 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.56 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.56 |
| ▸ | ADORA2A | P29274 | 4/20 | 0.55 |
| ▸ | ADORA2B | P29275 | 4/20 | 0.55 |
| ▸ | HSP90B1 | P14625 | 3/20 | 0.55 |
| ▸ | ADORA3 | P0DMS8 | 3/20 | 0.55 |
| ▸ | ADORA1 | P30542 | 3/20 | 0.55 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.55 |
| ▸ | HRH1 | P35367 | 1/20 | 0.55 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.55 |
| ▸ | TSHR | P16473 | 1/20 | 0.55 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.55 |
| ▸ | BLM | P54132 | 1/20 | 0.55 |
| ▸ | PRMT5 | O14744 | 1/20 | 0.54 |
| ▸ | WDR77 | Q9BQA1 | 1/20 | 0.54 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1972796 | 0.85 | AHCY (0.63) | AHCYTMEM97HIF1ASIGMAR1ADORA2A | |
| SCHEMBL6695446 | 0.85 | AHCY (0.53) | AHCYTMEM97HIF1ASIGMAR1ADORA2A | |
| SCHEMBL29877256 | 0.83 | AHCY (0.61) | AHCYTMEM97HIF1ASIGMAR1ADORA2A | |
| SCHEMBL28901883 | 0.83 | AHCY (0.61) | AHCYTMEM97HIF1ASIGMAR1ADORA2A | |
| SCHEMBL177772 | 0.83 | AHCY (0.61) | AHCYTMEM97HIF1ASIGMAR1ADORA2A | |
| SCHEMBL8661748 | 0.81 | AHCY (0.69) | AHCYTMEM97HIF1ASIGMAR1ADORA2A | |
| SCHEMBL8661561 | 0.81 | AHCY (0.69) | AHCYTMEM97HIF1ASIGMAR1ADORA2A | |
| SCHEMBL31680251 | 0.81 | AHCY (0.68) | AHCYTMEM97HIF1ASIGMAR1ADORA2A | |
| SCHEMBL397800 | 0.81 | AHCY (0.68) | AHCYTMEM97HIF1ASIGMAR1ADORA2A | |
| SCHEMBL7803295 | 0.80 | AHCY (0.67) | AHCYTMEM97HIF1ASIGMAR1ADORA2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 186 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2204154-B1 | Association of monosaccharides and adenosine and its cosmetic use | ORÉAL L (FR) | 2016-10-12 | — | — | EP | claimed |
| US-20100168049-A1 | COMBINATION OF MONOSACCHARIDES AND ADENOSINE AND USE THEREOF | L'OREAL (FR) | 2010-07-01 | — | — | US | claimed |
| US-20070232560-A1 | Treatment of skin with adenosine or adenosine analog | UNIVERSITY OF MASSACHUSETTS, A MASSACHUSETTS CORPORATION | 2007-10-04 | — | — | US | claimed |
| EP-1424064-B1 | Use of adenosin or an adenosin analog to smooth out fine lines | OREAL (FR) | 2007-06-06 | — | — | EP | claimed |
| US-20060240056-A1 | Treatment of skin with adenosine or adenosine analog | UNIVERSITY OF MASSACHUSETTS, A MASSACHUSETTS CORPORATION | 2006-10-26 | — | — | US | claimed |
| US-20040146474-A1 | Method for softening lines and relaxing the skin with adenosine and adenosine analogues | L'OREAL (FR) | 2004-07-29 | — | — | US | claimed |
| US-6020321-A | Adenosine receptor agonists for the promotion of wound healing | NEW YORK UNIVERSITY (US) | 2000-02-01 | — | — | US | claimed |
| US-5932558-A | PROMOTE MIGRATION OF ENDOTHELIAL CELLS, FIBROBLASTS AND EPITHELIAL CELLS | NEW YORK UNIVERSITY (US) | 1999-08-03 | — | — | US | claimed |
| US-5424297-A | Adenosine dextran conjugates | UNIVERSITY OF VIRGINIA ALUMNI PATENTS FOUNDATION (US) | 1995-06-13 | — | — | US | claimed |
| US-20260137604-A1 | COSMETIC COMPOSITIONS | L'OREAL (FR) | 2026-05-21 | — | — | US | disclosed |
| US-20260069521-A1 | COSMETIC COMPOSITION FOR IMPROVED PENETRATION | L'OREAL (FR) | 2026-03-12 | — | — | US | disclosed |
| EP-4440531-B1 | KIT AND METHOD FOR TREATING SKIN | OREAL (FR) | 2026-01-21 | — | — | EP | disclosed |
| US-12508217-B2 | Cosmetic compositions comprising high amounts of hydroxypropyl tetrahydropyrantriol | L'OREAL (FR) | 2025-12-30 | — | — | US | disclosed |
| US-12491146-B1 | Skin brightening compositions with thiopyridinone compound | L'OREAL (FR) | 2025-12-09 | — | — | US | disclosed |
| WO-1998022137-A1 | SUPPRESSION OF TNF α AND IL-12 IN THERAPY | THE KENNEDY INSTITUTE OF RHEUMATOLOGY (GB) | 1998-05-28 | — | — | WO | disclosed |
| WO-1998005357-A1 | ANTI-TNF ANTIBODIES AND METHOTREXATE IN THE TREATMENT OF AUTOIMMUNE DISEASE | THE KENNEDY INSTITUTE OF RHEUMATOLOGY (GB) | 1998-02-12 | — | — | WO | disclosed |
| WO-1997030088-A2 | METHODS OF TREATING VASCULAR DISEASE WITH TNF ANTAGONISTS | THE KENNEDY INSTITUTE OF RHEUMATOLOGY (GB) | 1997-08-21 | — | — | WO | disclosed |
| EP-0755255-A1 | TREATMENT OF TOXOPLASMOSIS | UNIVERSITY OF ALABAMA, BIRMINGHAM RESEARCH FOUNDATION (US) | 1997-01-29 | — | — | EP | disclosed |
| WO-1996018398-A1 | TREATMENT OF TOXOPLASMOSIS | THE UNIVERSITY OF ALABAMA AT BIRMINGHAM RESEARCH FOUNDATION (US) | 1996-06-20 | — | — | WO | disclosed |
| US-5424297-A | Adenosine dextran conjugates | UNIVERSITY OF VIRGINIA ALUMNI PATENTS FOUNDATION (US) | 1995-06-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260137604-A1 | COSMETIC COMPOSITIONS | TYR, CUTA, LAGE3 | AHCY 1793/4885TMEM97 2053/4885HIF1A 3976/4885 |
| US-12491146-B1 | Skin brightening compositions with thiopyridinone compound | GLMN, GNMT, GLA | AHCY 578/4885TMEM97 3071/4885HIF1A 4270/4885 |
| US-12508217-B2 | Cosmetic compositions comprising high amounts of hydroxypropyl tetrahydropyrantriol | CYP24A1, CYP2R1, CCND3 | AHCY 2211/4885TMEM97 1378/4885HIF1A 964/4885 |
| US-20260069521-A1 | COSMETIC COMPOSITION FOR IMPROVED PENETRATION | CUTA, SLC14A1, DSG1 | AHCY 196/4885TMEM97 923/4885HIF1A 2033/4885 |
| US-20100168049-A1 | COMBINATION OF MONOSACCHARIDES AND ADENOSINE AND USE THEREOF | ADORA2A, ADORA1, ADORA3 | AHCY 257/4885TMEM97 3704/4885HIF1A 1247/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.